<DOC>
	<DOCNO>NCT01242514</DOCNO>
	<brief_summary>The purpose study evaluate long term safety tolerability fostamatinib patient rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>Evaluation Long-term Safety Effectiveness Fostamatinib Treatment Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patients successfully complete qualify study ( D4300C00001 , D4300C00002 , D4300C00003 D4300C00004 ) fostamatinib Patients participate qualify study classify nonresponders due predefined lack efficacy Week 12 ( D4300C00001 , D4300C00002 , D4300C00003 ) . Premature withdrawal qualify study ( D4300C00001 , D4300C00002 , D4300C00003 D4300C00004 ) Females pregnant breast feed Poorly control hypertension Significant liver function test abnormality physical symptom hepatotoxicity Significant infection Gastrointestinal intolerance Cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>OSKIRA</keyword>
	<keyword>Fostamatinib</keyword>
</DOC>